Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

331 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
Meier JJ, Deifuss S, Klamann A, Schmiegel W, Nauck MA; LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA). Meier JJ, et al. Among authors: nauck ma. Exp Clin Endocrinol Diabetes. 2003 Sep;111(6):344-50. doi: 10.1055/s-2003-42725. Exp Clin Endocrinol Diabetes. 2003. PMID: 14520601
Plasma glucose at hospital admission and previous metabolic control determine myocardial infarct size and survival in patients with and without type 2 diabetes: the Langendreer Myocardial Infarction and Blood Glucose in Diabetic Patients Assessment (LAMBDA).
Meier JJ, Deifuss S, Klamann A, Launhardt V, Schmiegel WH, Nauck MA. Meier JJ, et al. Among authors: nauck ma. Diabetes Care. 2005 Oct;28(10):2551-3. doi: 10.2337/diacare.28.10.2551. Diabetes Care. 2005. PMID: 16186299 No abstract available.
Treatment with the human once-weekly glucagon-like peptide-1 analog taspoglutide in combination with metformin improves glycemic control and lowers body weight in patients with type 2 diabetes inadequately controlled with metformin alone: a double-blind placebo-controlled study.
Nauck MA, Ratner RE, Kapitza C, Berria R, Boldrin M, Balena R. Nauck MA, et al. Diabetes Care. 2009 Jul;32(7):1237-43. doi: 10.2337/dc08-1961. Epub 2009 Apr 14. Diabetes Care. 2009. PMID: 19366970 Free PMC article. Clinical Trial.
331 results